SHLP-2 Research for Age-Related Macular Degeneration
An evidence-based overview of research examining SHLP-2 in the context of age-related macular degeneration. This page synthesizes findings from peer-reviewed literature.
Research Summary
In vitro studies using retinal pigment epithelium cells from AMD patients showed SHLP-2 improved mitochondrial function, increased mtDNA copy numbers, and enhanced PGC-1a expression. These findings suggest potential for mitochondrial-targeted AMD therapy, but remain limited to cell culture models.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Age-Related Macular Degeneration
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. SHLP-2 has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.